Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy

Raffaele Dubbioso, Pasquale Moretta, Fiore Manganelli, Chiara Fiorillo, Rosa Iodice, Luigi Trojano, Lucio Santoro

Research output: Contribution to journalArticle

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant disorder caused by a small expansion of a short polyalanine tract in poly(A) binding protein nuclear 1 (PABPN1). It presents with adult onset of progressive eyelid drooping, swallowing difficulties and proximal limb weakness, usually without involvement of central nervous system (CNS). However, cognitive decline with relevant behavioural and psychological symptoms has been recently described in homozygous patients. In this study, we performed for the first time an extensive neuropsychological and neuropsychiatric evaluation on 11 OPMD heterozygote patients. We found that they were less efficient than a matched control sample on several tests, particularly those tapping executive functions. Moreover, the presence of negative correlation between GCN expansion size and some neuropsychological scores raises the issue that CNS involvement might be linked to the genetic defect, being worse in patients with larger expansion. Our results might be consistent with the toxic gain-of-function theory in the pathogenesis of OPMD and hint at a possible direct role of PABPN1 in the CNS also in heterozygote patients.

Original languageEnglish
Pages (from-to)833-837
Number of pages5
JournalJournal of Neurology
Volume259
Issue number5
DOIs
Publication statusPublished - May 2012

Fingerprint

Oculopharyngeal Muscular Dystrophy
Executive Function
Heterozygote
Poly(A)-Binding Protein II
Central Nervous System
Behavioral Symptoms
Poisons
Eyelids
Deglutition
Extremities
Psychology

Keywords

  • Central nervous system
  • Executive defects
  • GCN expansion
  • Heterozygote patients
  • Oculopharyngeal muscular dystrophy
  • Psychiatric disturbances

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy. / Dubbioso, Raffaele; Moretta, Pasquale; Manganelli, Fiore; Fiorillo, Chiara; Iodice, Rosa; Trojano, Luigi; Santoro, Lucio.

In: Journal of Neurology, Vol. 259, No. 5, 05.2012, p. 833-837.

Research output: Contribution to journalArticle

Dubbioso, R, Moretta, P, Manganelli, F, Fiorillo, C, Iodice, R, Trojano, L & Santoro, L 2012, 'Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy', Journal of Neurology, vol. 259, no. 5, pp. 833-837. https://doi.org/10.1007/s00415-011-6255-y
Dubbioso, Raffaele ; Moretta, Pasquale ; Manganelli, Fiore ; Fiorillo, Chiara ; Iodice, Rosa ; Trojano, Luigi ; Santoro, Lucio. / Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy. In: Journal of Neurology. 2012 ; Vol. 259, No. 5. pp. 833-837.
@article{c638b0f4949f4d2d9350494a0cbdc4e9,
title = "Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy",
abstract = "Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant disorder caused by a small expansion of a short polyalanine tract in poly(A) binding protein nuclear 1 (PABPN1). It presents with adult onset of progressive eyelid drooping, swallowing difficulties and proximal limb weakness, usually without involvement of central nervous system (CNS). However, cognitive decline with relevant behavioural and psychological symptoms has been recently described in homozygous patients. In this study, we performed for the first time an extensive neuropsychological and neuropsychiatric evaluation on 11 OPMD heterozygote patients. We found that they were less efficient than a matched control sample on several tests, particularly those tapping executive functions. Moreover, the presence of negative correlation between GCN expansion size and some neuropsychological scores raises the issue that CNS involvement might be linked to the genetic defect, being worse in patients with larger expansion. Our results might be consistent with the toxic gain-of-function theory in the pathogenesis of OPMD and hint at a possible direct role of PABPN1 in the CNS also in heterozygote patients.",
keywords = "Central nervous system, Executive defects, GCN expansion, Heterozygote patients, Oculopharyngeal muscular dystrophy, Psychiatric disturbances",
author = "Raffaele Dubbioso and Pasquale Moretta and Fiore Manganelli and Chiara Fiorillo and Rosa Iodice and Luigi Trojano and Lucio Santoro",
year = "2012",
month = "5",
doi = "10.1007/s00415-011-6255-y",
language = "English",
volume = "259",
pages = "833--837",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "5",

}

TY - JOUR

T1 - Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy

AU - Dubbioso, Raffaele

AU - Moretta, Pasquale

AU - Manganelli, Fiore

AU - Fiorillo, Chiara

AU - Iodice, Rosa

AU - Trojano, Luigi

AU - Santoro, Lucio

PY - 2012/5

Y1 - 2012/5

N2 - Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant disorder caused by a small expansion of a short polyalanine tract in poly(A) binding protein nuclear 1 (PABPN1). It presents with adult onset of progressive eyelid drooping, swallowing difficulties and proximal limb weakness, usually without involvement of central nervous system (CNS). However, cognitive decline with relevant behavioural and psychological symptoms has been recently described in homozygous patients. In this study, we performed for the first time an extensive neuropsychological and neuropsychiatric evaluation on 11 OPMD heterozygote patients. We found that they were less efficient than a matched control sample on several tests, particularly those tapping executive functions. Moreover, the presence of negative correlation between GCN expansion size and some neuropsychological scores raises the issue that CNS involvement might be linked to the genetic defect, being worse in patients with larger expansion. Our results might be consistent with the toxic gain-of-function theory in the pathogenesis of OPMD and hint at a possible direct role of PABPN1 in the CNS also in heterozygote patients.

AB - Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant disorder caused by a small expansion of a short polyalanine tract in poly(A) binding protein nuclear 1 (PABPN1). It presents with adult onset of progressive eyelid drooping, swallowing difficulties and proximal limb weakness, usually without involvement of central nervous system (CNS). However, cognitive decline with relevant behavioural and psychological symptoms has been recently described in homozygous patients. In this study, we performed for the first time an extensive neuropsychological and neuropsychiatric evaluation on 11 OPMD heterozygote patients. We found that they were less efficient than a matched control sample on several tests, particularly those tapping executive functions. Moreover, the presence of negative correlation between GCN expansion size and some neuropsychological scores raises the issue that CNS involvement might be linked to the genetic defect, being worse in patients with larger expansion. Our results might be consistent with the toxic gain-of-function theory in the pathogenesis of OPMD and hint at a possible direct role of PABPN1 in the CNS also in heterozygote patients.

KW - Central nervous system

KW - Executive defects

KW - GCN expansion

KW - Heterozygote patients

KW - Oculopharyngeal muscular dystrophy

KW - Psychiatric disturbances

UR - http://www.scopus.com/inward/record.url?scp=84862583612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862583612&partnerID=8YFLogxK

U2 - 10.1007/s00415-011-6255-y

DO - 10.1007/s00415-011-6255-y

M3 - Article

C2 - 21956377

AN - SCOPUS:84862583612

VL - 259

SP - 833

EP - 837

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 5

ER -